Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms

被引：23

作者：

de Almeida, Viviani ^{[1
]}

Engel, Daiane F. ^{[2
]}

Ricci, Mayra F. ^{[1
]}

Cruz, Clenio Silva ^{[1
]}

Lopes, Icaro Santos ^{[3
]}

Alves, Daniele Almeida ^{[4
]}

D' Auriol, Mirna ^{[5
]}

Magalhaes, Joao ^{[1
]}

Machado, Elayne C. ^{[1
]}

Rocha, Victor M. ^{[1
]}

Carvalho, Toniana G. ^{[6
]}

Lacerda, Larisse S. B. ^{[7
]}

Pimenta, Jordane C. ^{[7
]}

Aganetti, Mariana ^{[1
]}

Zuccoli, Giuliana S. ^{[8
]}

Smith, Bradley J. ^{[8
]}

Carregari, Victor C. ^{[8
]}

Rosa, Erika da Silva ^{[1
]}

Galvao, Izabela ^{[1
]}

Cassali, Geovanni Dantas ^{[9
]}

Garcia, Cristiana C. ^{[10
]}

Teixeira, Mauro Martins ^{[7
]}

Andre, Leiliane C. ^{[5
]}

Ribeiro, Fabiola Mara ^{[6
]}

Martins, Flaviano S. ^{[11
]}

Saia, Rafael Simone ^{[12
]}

Costa, Vivian Vasconcelos ^{[7
]}

Martins-de-Souza, Daniel ^{[8
,13
,14
,15
]}

Hansbro, Philip M. ^{[16
,17
]}

Marques, Joao Trindade ^{[4
,18
]}

Aguiar, Eric R. G. R. ^{[3
]}

Vieira, Angelica T. ^{[1
,19
]}

机构：

[1] Univ Fed Minas Gerais UFMG, Inst Biol Sci, Dept Biochem & Immunol, Lab Microbiota & Immunomodulat, Belo Horizonte, Brazil

[2] Univ Fed Ouro Preto UFOP, Sch Pharm, Dept Clin Anal, Ouro Preto, Brazil

[3] Univ Estadual Santa Cruz UESC, Ctr Biotechnol & Genet, Dept Biol Sci, Lab Virus Bioinformat, Ilheus, Brazil

[4] Univ Fed Minas Gerais UFMG, Inst Biol Sci, Dept Biochem & Immunol, Lab RNA Interference & Antiviral Immun, Belo Horizonte, Brazil

[5] Univ Fed Minas Gerais UFMG, Fac Pharm, Dept Clin & Toxicol Anal, Lab Toxicol, Belo Horizonte, Brazil

[6] Univ Fed Minas Gerais UFMG, Inst Biol Sci, Dept Biochem & Immunol, Lab Neurobiochem, Belo Horizonte, Brazil

[7] Univ Fed Minas Gerais UFMG, Inst Biol Sci, Ctr Res & Dev Drugs, Dept Morphol, Belo Horizonte, Brazil

[8] Univ Estado Campinas UNICAMP, Inst Biol, Dept Biochem & Tissue Biol, Lab Neuroproteom, Campinas, Brazil

[9] Univ Fed Minas Gerais UFMG, Dept Pathol, Lab Comparat Pathol, Belo Horizonte, Brazil

[10] Inst Oswaldo Cruz Fiocruz, Lab Resp Viruses & Measles, Rio de Janeiro, Brazil

[11] Univ Fed Minas Gerais UFMG, Inst Biol Sci, Dept Microbiol, Lab Biotherapeut Agents, Belo Horizonte, Brazil

[12] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Physiol, Lab Intestinal Physiol, Ribeirao Preto, Brazil

[13] DOR Inst Res & Educ, Sao Paulo, Brazil

[14] Univ Estado Campinas UNICAMP, Expt Med Res Cluster, Campinas, Brazil

[15] Natl Inst Biomarkers Neuropsychiat, Natl Council Sci & Technol Dev, Sao Paulo, Brazil

[16] Univ Technol Sydney, Centenary Inst, Ctr Inflammat, Sydney, Australia

[17] Univ Technol Sydney, Sydney, Australia

[18] Univ Strasbourg, CNRS UPR9022, Strasbourg, France

[19] Univ Fed Minas Gerais UFMG, Inst Biol Sci, Lab Microbiota & Immunomodulat, Av Pres Antonio Carlos,6627, Belo Horizonte, Brazil

来源：

GUT MICROBES | 2023年 / 15卷 / 02期

关键词：

COVID-19; SARS-CoV-2; post-COVID; microbiota; inflammation; antimicrobial-resistance; SARS-COV-2; RNA; INFECTION; MODEL; DISEASE; HUMANS;

D O I：

10.1080/19490976.2023.2249146

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Long-term sequelae of coronavirus disease (COVID)-19 are frequent and of major concern. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection affects the host gut microbiota, which is linked to disease severity in patients with COVID-19. Here, we report that the gut microbiota of post-COVID subjects had a remarkable predominance of Enterobacteriaceae strains with an antibiotic-resistant phenotype compared to healthy controls. Additionally, short-chain fatty acid (SCFA) levels were reduced in feces. Fecal transplantation from post-COVID subjects to germ-free mice led to lung inflammation and worse outcomes during pulmonary infection by multidrug-resistant Klebsiella pneumoniae. transplanted mice also exhibited poor cognitive performance. Overall, we show prolonged impacts of SARS-CoV-2 infection on the gut microbiota that persist after subjects have cleared the virus. Together, these data demonstrate that the gut microbiota can directly contribute to post-COVID sequelae, suggesting that it may be a potential therapeutic target.

引用

页数：22

共 50 条

[31] Post-COVID Lymphadenopathy in Patient with Remote COVID-19 Infection
Stewart, Chelsey Danielle
Baker, M. Hayes
SOUTHERN MEDICAL JOURNAL, 2021, 114 (08)
[32] Post-COVID symptoms and mental health status 13-18 months post COVID-19 infection
Frankenthal, Dvora
Karni-Efrati, Ziv
Zatlawi, Miri
Keinan-Boker, Lital
Bromberg, Michal
JOURNAL OF PUBLIC HEALTH-HEIDELBERG, 2024,
[33] Post-COVID syndrome and pain perception in outpatients with COVID-19
Tas, A.
Baloglu, M.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (14) : 6901 - 6910
[34] Impact of COVID-19 vaccination in post-COVID cardiac complications
Parodi, Josefina B.
Indavere, Agustin
Jacob, Pamela Bobadilla
Toledo, Guillermo C.
Micali, Ruben G.
Waisman, Gabriel
Masson, Walter
Epstein, Eduardo D.
Huerin, Melina S.
VACCINE, 2023, 41 (08) : 1524 - 1528
[35] Alterations in microbiota of patients with COVID-19: implications for therapeutic interventions
Qiu, Yong
Mo, Chunheng
Chen, Lu
Ye, Wanlin
Chen, Guo
Zhu, Tao
MEDCOMM, 2024, 5 (04):
[36] The metaproteome of the gut microbiota in pediatric patients affected by COVID-19
Marzano, Valeria
Mortera, Stefano Levi
Marangelo, Chiara
Piazzesi, Antonia
Rapisarda, Federica
Pane, Stefania
Del Chierico, Federica
Vernocchi, Pamela
Romani, Lorenza
Campana, Andrea
Palma, Paolo
Putignani, Lorenza
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
[37] COVID-19 and Post-COVID Outcomes in Lung Cancer Patients: Experience from an Indian Cancer Center
Mondal, D.
Ganguly, S.
Roy, S.
Ghosh, J.
Chatterji, S.
Biswas, B.
JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S303 - S304
[38] Systemic inflammatory response and thrombosis due to alterations in the gut microbiota in COVID-19
Moenkemueller, Klaus
Fry, Lucia C.
Rickes, Steffen
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2020, 112 (07) : 584 - 584
[39] Post-COVID interstitial lung disease in symptomatic patients after COVID-19 disease
Fesu, Dorottya
Polivka, Lorinc
Barczi, Eniko
Foldesi, Marcell
Horvath, Gabor
Hidvegi, Edit
Bohacs, Aniko
Muller, Veronika
INFLAMMOPHARMACOLOGY, 2023, 31 (02) : 565 - 571
[40] Post-COVID interstitial lung disease in symptomatic patients after COVID-19 disease
Dorottya Fesu
Lorinc Polivka
Eniko Barczi
Marcell Foldesi
Gabor Horvath
Edit Hidvegi
Aniko Bohacs
Veronika Muller
Inflammopharmacology, 2023, 31 : 565 - 571

← 1 2 3 4 5 →